Rare events screening & characterization

We are building a fourth-generation Artificial Intelligence (GEN-IV AI) to empower researchers, startups, and the healthtech industry to advance their understanding of rare events through integrated multi-year risk modeling, uncertainties quantification, and early weak signals characterization.

Research-only • No medical advice

A deeptech platform built for deeptech

Scalable by Design
Designed for scalability with cloud-native architecture, enabling reproducible, clinical-grade research workflows.
Secure & Compliant
Privacy-first posture with GDPR-aligned processes, advanced quantification and probabilistic modeling and simulation.
AI for Rare & Complex Events
Weak signals characterization beyond traditional analytics, associated with rare events risk modeling and assessment.
Collaboration beyond code

From research to impact

Work with scientific partners, clinical teams, and R&D stakeholders through a shared language: assumptions, uncertainty, and evidence trails.

  • Shared review workflow with structured artifacts
  • Traceable assumptions and uncertainty tags
  • Export-ready packs for institutional review
"The value is not just AI — it's a reviewable process where conservative outputs and audit trails keep teams aligned."
Scientific collaborator (anonymized)
Hope Metrix • Dashboard
Workflows
Screening
Risks
Compliance
Exports
Weak-signal detection
Rare event screening overview
Audit-ready
Uncertainty bands
Reviewer notes
Mockup for illustration: structured workflows, conservative outputs, and traceability designed for scientific review.

Offer tiers for teams at different stages

Choose the program that best fits your needs and aligns with your deeptech project.

Founders & Startups
Platform access + screening toolkit for research teams who need a structured, conservative workflow from day one.
  • Core screening workflows (rare-event oriented)
  • Audit-ready artifacts and exports
  • Collaboration + reviewer notes
Research & Enterprise
Recommended
For organizations that need integration, validation support, and custom pipelines aligned with internal governance and security requirements.
  • Integrations + custom data flows
  • Validation and evaluation support
  • Custom pipelines for specialized domains
Clinical & Pilot Programs
Co-development and bespoke deployment for pilot studies, institutional partners, and translational research — with careful boundaries and positioning.
  • Co-design for a targeted pilot
  • Bespoke deployment options
  • Joint governance and review packs
Get started

Ready to build the future of GEN-IV AI ?

Share your use-case, needs and constraints. We will identify the most relevant entry point and illustrate how GEN-IV AI is fundamentally built around trust, ethics, risk assessment, security, full traceability, and regulatory compliance.

Research-only positioning. No clinical decision-making.